GSK plc reported on November 12, 2025, the interim review of its block listing for the period from May 1, 2025, to October 31, 2025, indicating 115,518 unallotted securities under the Deferred Annual Bonus Plan and 135,768 under the Share Save Plan 2012 after issuing 134,547 securities during this period.